Metabolic Phenotyping:
We measure metabolic pathway activity (Single-Cell, Tissue, FFPE)
Lab Services
Integrated Proteomic, Transcriptomic, Metabolic Analysis
Data Services
Triple-Omics Data Integration for Enhanced Insights
Sample Analysis
Cells, Organoids & Tissues, Including FFPE Samples
Innovation Alert
Introducing Single-Cell Metabolic Phenotyping Services
Applications
QSM™ Biomarkers (Quantitative System Metabolism) are used in drug discovery and in pre-clinical and clinical studies across a range of disease areas including drug safety assessments.
Disease Area
Oncology
Drug Safety
Metabolic Disorders
Longevity
Cardiology
Neurology
Study Phase
Preclinical biomarkers
Drug Safety Biomarkers
Clinical Biomarkers
Clinical Biomarkers
Clinical Biomarkers
Discovery
Download Case Study
Drug-Induced Liver Injury (DILI)
Applications
About Doppelganger
Based in Germany, Doppelganger Biosystem GmbH offers QSM™ Metabolic Phenotyping services. QSM™ (Quantitative System Metabolism) stands as the pioneering analytical platform for quantifying biomarkers of metabolic pathway activity in single cells and tissues, including FFPE samples. QSM™ supports preclinical, clinical, and translational scientists with actionable insights into the activity of 22 cellular metabolic pathways.
Want to learn more about QSM™?
Contact
Doppelganger Biosystem GmbH
Rebenstrasse 22
26121 Oldenburg, Germany
Phone North America:
+1 617 500-8221
Phone Europe:
+49 441 30446185